🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 23282W605 (prev. 23282W100 )
- Market Cap
- Small Cap · $468 Million
Business: Cytokinetics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Cytokinetics’ research and development activities relating to the biology of muscle function have evolved from a knowledge and expertise regarding the cytoskeleton, a complex biological infrastructure that plays a fundamental role within every human cell. Cytokinetics’ current research and development programs relating to the biology of muscle function are directed to small molecule modulators of the contractility of cardiac, skeletal and smooth muscle.
Company Contact
- CEO
- Robert I. Blum
- CFO
- Ching W. Jaw
- Headquarters
- 280 East Grand Avenue, South San Francisco, CA 94080
- Phone
- 650-624-3000
- Fax
- 650-624-3070
- Investor Relations
- Diane Weiser · 650-624-3060 · investor@cytokinetics.com